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ABSTRACT
Cultured cortical primary astroglia treated with zinc died while rapidly detached from 
culture plates, a distinct part of zinc-treated astroglia. In the present study, we 
investigated the mechanism underlying the rapid change in the morphologic integrity of 
zinc-treated astroglia. Among the early cellular events occurring in zinc-treated 
astroglia, strong activation of p38 MAPK and JNK was evident. Although inhibitors of 
p38 (SB203580 and SB202190) or JNK (SP600125) did not protect zinc-insulted 
astroglia from cell death, the p38 inhibitors, but not the JNK inhibitor, suppressed actin 
filament and cell morphology disruption. The Ca
2＋ ionophore, A23187, also suppress-
ed actin filament and cell morphology disruption, but not cell death, of zinc-insulted 
astroglia. However, A23187 did not inhibit p38 MAPK activation in zinc-treated 
astroglia. Together these results suggest that zinc influx in astroglia results in rapid 
loss of the morphologic integrity via mechanisms regulated by p38 kinase and/or Ca
2＋ 
signaling.
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INTRODUCTION
    Acute  pathologic  conditions,  such  as  cerebral 
ischemia,  induce  excess  release  of  free  zinc  from 
excitatory  synapses,  and  excessively  released  zinc 
causes brain cells to die (Frederickson et al., 2005). 
Zinc-induced  cell  death  occurs  via  zinc  influx  into 
cells,  and  zinc  influx  results  in  disruption  of  thiol 
homeostasis  and  reactive  oxygen  species  (ROS) 
stress (Frederickson et al., 1988; Kim et al., 1999a; 
1999b;  Suh  et  al.,  2000;  Kim  et  al.,  2003).  In  vitro 
studies have shown that both neurons and astroglia 
are  sensitive  to  chronic  low  doses  of  free  zinc 
(Dineley et al., 2000; Cho et al., 2003; Ralph et al., 
2010).  Cultured  primary  astroglia  cells  challenged 
with  free  zinc  become  elongated  in  shape,  swell 
and  soon  thereafter  detach  from  the  culture  plate. 
The  rapid  change  and  characteristic  loss  of  mor-
phologic integrity of astroglia cells precedes with the 
events  leading  to  cell  death  (Cho  et  al.,  2003;  Kim 
et al., 2003). Astroglial cell death induced by zinc is 
different from that of other insults, such as H2O2 or 
Fe
2＋,  in  that  astroglia  cells  treated  with  the  latter 
stimulants  undergo  demise,  while  most  cells  are 
attached  on  the  culture  plate.  Cell  morphology 
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plate,  might  proceed  with  disruption  of  cytoskeletal 
elements.  Because  zinc-induced  astroglia  death  is 
initiated  by  zinc-influx  (Ryu  et  al.,  2002;  Kim  et  al., 
2003),  the  rapid  and  distinct  loss  of  morphologic 
integrity is likely to occur via zinc-mediated changes 
in dynamics of cytoskeletal elements. However, it is 
unclear how this process occurs and whether intra-
cellular  cytoskeleton  dysregulation  is  a  prerequisite 
to  the  cell  death  process  in  zinc-insulted  cells.
    Actin  is  the  major  cytoskeletal  element  in  most 
eukaryotic  cells.  Failure  of  actin  dynamics  leads  to 
disruption  of  cell  morphology  (Carlier  et  al.,  1994; 
Dalle-Donne  et  al.,  2001).  Actin  dynamics  and  cell 
morphology  have  been  shown  to  be  regulated  by 
several  factors,  including  mitogen-activated  protein 
kinases  (MAPKs).  For  instance,  the  MEK  inhibitor, 
U0126,  blocks  stellate  process  extension  of  fibro-
blast  growth  factor  2  (FGF2)-treated  astroglia  in 
vitro,  while  inhibition  of  the  p38  MAPK  pathway  by 
SB202190  facilitate  stellate  process  growth  and 
extension  of  the  same  cells  (Heffron  and  Mandell, 
2005).  The  p38  MAPK  cascade  regulates  actin 
polymerization  in  platelet-derived  growth  factor-in-
duced  cytoskeleton  remodeling  of  aortic  smooth 
muscle  cells  (Pichon  et  al.,  2004).  p38  MAPK 
activation  induces  actin  re-arrangements  in  VEGF- 
treated  human  endothelial  cells  (Rousseau  et  al., 
1997).  MAPK  activated  protein  kinase  2  regulates 
actin  polymerization  in  ventilator  associated  lung 
injury  (Damarla  et  al.,  2009).
    Intracellular Ca
2+ homeostasis is also important in 
the  maintenance  of  cell  morphology.  Calcium 
stimulates  actin  filament  assembly  (Downey  et  al., 
1990; Carlier et al., 1994), and Ca
2+-mediated actin 
filament  regulation  contributes  to  growth  cone 
behaviors,  synaptic  vesicle  trafficking  in  presynaptic 
terminals,  and  synaptic  plasticity  in  dendritic  spines 
of  postsynaptic  neurons  (Matus,  2000;  Levitan, 
2008).  Calcium  also  activates  Ca
2+-dependent  pro-
teases,  for  examples  calpains,  that  cleave  actin- 
binding proteins, dissociating the anchorage between 
the plasma membrane and cytoskeleton (Harris and 
Morrow,  1990;  Carragher  and  Frame,  2002). 
    MAPKs  are  important  elements  in  neuronal  and 
non-neuronal  cell  death  (Wang  et  al.,  1998;  Guo 
and  Bhat,  2007).  Zinc  influx  stimulates  MAPK 
pathways in neuronal cells (Seo et al., 2001; An et 
al.,  2005).  ERK1/2  signaling  leads  to  mitochondrial 
dysfunction  in  extracellular  zinc-induced  neurotoxi-
city  in  rat  cultured  neurons  (He  and  Aizenman, 
2010).  In  the  present  study,  we  explored  the  me-
chanisms  that  underlie  rapid  changes  in  the  mor-
phologic  integrity  of  zinc-treated  astroglia.
MATERIALS  AND  METHODS
Primary  neuronal  and  astroglial  cultures
    Primary  cortical  neuron  and  astroglia  were  cul-
tured, as described previously (Cho et al., 2003; Im 
et  al.,  2006a).  Primary  cortical  neuronal  cultures 
were  prepared  from  embryonic  day  15.5  (E15.5) 
ICR  mouse  cortices.  Mouse  cortices  were  triturated 
and dissociated cortical cells were plated in minimal 
essential medium (MEM) supplemented with 20 mM 
glucose,  5%  fetal  bovine  serum  (FBS),  5%  horse 
serum,  and  2  mM  glutamine,  at  a  density  of  5 
hemispheres  per  plate  (4×10
5  cells  per  well)  onto 
poly-D-lysine  (100μg/ml)  and  laminin  (4μg/ml) 
coated  24-well  plates.  On  day  6  in  vitro  (DIV6), 
cytosine  arabinoside  was  added  to  a  final  con-
centration  of  10μM  and  maintained  for  2  days  to 
halt  glial  growth.  FBS  and  glutamine  were  not 
supplemented  in  the  culture  medium  from  day  6, 
and  the  medium  was  changed  twice  a  week  after 
day 8. Cultures in DIV13-15 were used for studies. 
When  treated  with  zinc  and/or  drugs,  HEPES- 
buffered  salt  solution  (120  mM  NaCl,  5.4  mM  KCl, 
0.8 mM MgCl2, 1.8 mM CaCl2, 20 mM HEPES, 10 
mM  NaOH,  and  15  mM  glucose)  was  used.
    Cortical  astroglia  cells  were  cultured,  as  describ-
ed  previously  (Cho  et  al.,  2003;  Im  et  al.,  2006b). 
ICR  neonatal  mice  (day  0-1)  were  sacrificed  and 
the  cortices  were  isolated.  Dissociated  cortical  cells 
were  plated  in  MEM  supplemented  with  20  mM 
glucose, 5% fetal bovine serum, 5% horse serum, 2 
mM  glutamine,  50μg/ml  streptomycin,  and  50 
unit/ml  penicillin  at  a  density  of  2  hemispheres  per 
plate  (5×10
4  cells  per  well)  onto  poly-D-lysine-coat-
ed (20μg/ml) 24-well plates. Cells were maintained 
at  37
oC  in  a  humidified  5%  CO2  incubator.  The 
medium  was  changed  twice  a  week.  The  experi-
ments  were  carried  out  on  cells  which  were  grown 
to  confluence,  and  obtained  after  2  weeks  of 
culturing.  Cortical  astroglia  cultures  were  charac-
terized  by  anti-GFAP  antibody  (Dako,  Carpinteria, 
CA,  USA),  an  astrocyte  marker,  and  isolectin  B4 p 3 8  M A P K  a n d  C a
2＋-regulated  Cell  Morphology  Regulation 47
conjugated  antibody  (Sigma,  St.  Louis,  MO,  USA), 
a microglia marker, as described previously (Cho et 
al.,  2003).  Various  inhibitors  or  drugs,  including 
SB203580  and  SB202190,  were  obtained  from 
Calbiochem  (La  Jolla,  CA,  USA).
Western  blot  analysis
    Western  blot  analysis  was  carried  out  as  des-
cribed previously (Im et al., 2006a). Briefly, primary 
astroglia  were  suspended  in  lysis  buffer  containing 
150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium 
deoxycholate,  1  mM  phenylmethylsulfonyl  fluoride 
(PMSF),  1  mM  Sodium  orthovanadate  (Na3VO4), 
and  protease  inhibitor  cocktails  (Roche,  Basel, 
S w i s s )  i n  2 0  m M  T r i s - H C l  ( p H  7 . 4 ) .  L y s a t e s  w e r e  
centrifuged  for  10  min  at  12,000  rpm  at  4
oC,  and 
the  resulting  supernatants  were  collected.  Protein 
contents were determined using a bicinchoninic acid 
assay  kit  (St.  Louis,  MO,  USA).  Protein  samples 
were electrophoresed by 10% SDS-PAGE and then 
transferred  to  polyvinylidene  difluoride  membranes 
(Bio-Rad,  Hercules,  CA,  USA).  The  blots  were 
blocked  with  5%  non-fat  dried  milk  for  1  h  and 
incubated  with  primary  antibodies  overnight  at  4
oC. 
The secondary antibody was incubated for 1 h and 
specific  signals  were  detected  using  an  enhanced 
chemiluminescence  (ECL)  kit  (Amersham,  Bucking-
hamshire,  UK).  Immunoblotting  was  performed 
using  polyclonal  anti-phospho-p38  (1：1,000,  Cell 
signaling,  USA),  polyclonal  anti-phospho-JNK  (1：
1,000, Cell signaling, USA), polyclonal anti-p38 (1：
1,000,  Santa  Cruz,  CA,  USA),  and  monoclonal 
anti-JNK1  (1：1,000,  Pharmingen,  USA).
Assessments  of  cell  death
    Cell  death  was  assessed  by  measuring  the 
activity  of  lactate  dehydrogenase  (LDH)  released  in 
culture  medium  as  described  previously  (Im  et  al., 
2006a).  Culture  medium  was  collected  24  h  after 
drug  treatment  to  use  for  LDH  activity  unless 
indicated  otherwise.  Twenty-five  μl  of  culture  me-
dium was transferred to a microplate and 100μl of 
NADH  solution  (0.3  mg/ml  NADH  and  0.1  M 
potassium  phosphate,  pH  7.4)  was  added  to  the 
medium.  Subsequently  after  2  min,  25μl  of  pyru-
vate  solution  (22.7  mM  pyruvate  and  0.1  M  pota-
ssium  phosphate,  pH  7.4)  was  added.  After  adding 
pyruvate  solution,  the  decrease  of  absorbance  at 
340 nm, which indicates the conversion of NADH to 
NAD
＋,  was  measured  by  SpectraMax  microplate 
reader  (Molecular  Device,  Sunnyvale,  USA).  LDH 
activity was normalized in  that sham-treated culture 
and  culture  showing  complete  cell  death  were  0% 
and  100%,  respectively,  and  normalized  LDH  acti-
vity  was  regarded  as  an  indicator  of  cell  death. 
Complete  cell  death  was  induced  by  treatment  of 
cells  to  2  mM  H2O2  for  24  h.  Cell  death  was  also 
confirmed  by  trypan  blue  staining,  and  by  mor-
phological  changes  on  phase  contrast  microscope.
Immunofluorescence-labeled  phalloidin  stain-
ing  of  F-actin
    Visualization  of  actin  filament  distribution  in  cells 
was  performed  as  described  previously  (Chae  et 
al.,  2006).  Cortical  cells  were  fixed  by  4%  parafor-
maldehyde solution for 10 min at room temperature 
and  washed  in  PBS  twice.  Then  the  cells  were 
treated  with  0.5%  triton  X-100  in  PBS  to  help 
penetration  of  phalloidin.  After  being  washed,  the 
cells  were  stained  with  0.4μg/ml  phalloidin-TRITC 
(Sigma,  St  Louis,  MO,  USA)  for  90  min  at  4
oC. 
Stained  cells  were  photographed  by  fluorescence 
light  microscope  (Axiovert  200,  Carl  Zeiss  Micro-
Imaging,  Inc.,  USA).
Statistical  analysis
    All  data  were  analyzed  using  Student  t-test  for 
comparisons between two samples or using ANOVA 
followed  by  the  Newman-Keuls  test.  A  statistical 
difference  was  accepted  at  5%  level.
RESULTS
Zinc-treated  astroglia  showed  strong  activa-
tion  of  p38  and  JNK  MAPKs
    Astroglial  cells  insulted  with  zinc  were  elongated 
in  shape  after  6  h,  then  gradually  swelled  and 
detached from the bottom of culture plate after 9 h. 
The  rapid  loss  of  morphological  integrity  in  zinc- 
treated  cells  proceeded  in  parallel  with  the  cellular 
process  leading  to  cell  death  as  demonstrated  in 
previous  studies  (Cho  et  al.,  2003;  Kim  et  al., 
2003).  To  understand  the  mechanism  underlying 
the  extraordinarily  rapid  changes  in  cell’s  integrity 
and  cell  death  processes  of  zinc-treated  cells,  we 
tested  whether  p38  and  JNK  were  involved.  As 48 Joo-Young  Im,  et  al.
Fig.  1.  p38  and  JNK  MAPKs  were  activated  in  zinc-treated 
astroglia.  (A,  B)  Astroglial  cell  death  by  zinc  increased  in  a 
zinc-dose (A) and zinc- treated time (B) dependent manner. LDH 
assay was performed after 24 h-exposure of cultures to indicated 
concentrations  of  zinc.  (C)  Western  blots  showing  zinc-dose 
dependent activation of p38 and JNK MAPKS in astroglia. Assay 
was performed 3 h after zinc treatment. Anti-phospho- p38 MAPK 
and anti-phospho-JNK were used to  deduce the activation levels 
of  these  kinases.  (D)  Western  blots  showing  time-dependent 
activation  of  p38  and  JNK  MAPKS  in  zinc  (35μM)-treated 
astroglia.
Fig.  2.  The  p38  MAPK  inhibitor,  SB203580,  suppressed  zinc- 
induced  morphology  disruption  and  detachment  from  the  culture 
plate.  (A∼H )  P h a s e  c o n t r a s t  ( A ∼D)  or  trypan-blue  stained  (E∼
H)  astroglia  with  sham  treatment  (A,  E)  or  astroglia  treated  with 
zinc  (B,  F),  with  zinc  and  SP600125  (C,  G),  or  with  zinc  and 
SB203580  (D,  H).  Photomicrographs  were  taken  24  h  after  zinc 
(35μM)-treatment  in  the  presence  of  SP600125  (20μM)  or 
SB203580 (20μM). Scale bar represents 100μm. (I) LDH assay 
showing cell death levels of zinc (35μM)-treated astroglia in the 
presence  of  PD98059  (PD:  20μM),  SP600125  (SP:  20μM),  or 
SB203580  (SB:  20μM).  LDH  assay  was  performed  24  h  after 
zinc  treatment.
reported  previously  (Cho  et  al.,  2003;  Kim  et  al., 
2003),  zinc-dose  and  zinc-treated  time  dependent 
astroglial  deaths  were  observed  (Fig.  1A  and  B). 
Western  blot  analysis  using  anti-phospho-p38  or 
anti-phospho-JNK  showed  that  both  MAPKs  were 
activated  in  3  h  after  zinc  challenge  in  a  zinc-dose 
dependent  manner  (Fig.  1C).  The  activation  of  p38 
MAPK by zinc (35μM) was maximal at ∼3 h after 
zinc  challenge,  and  thereafter  were  slowly  declined 
(Fig.  1D).
p38  MAPK  inhibitors  suppressed  cell  mor-
phology  disruption  of  zinc-insulted  astroglia
    We  examined  whether  p38  and  JNK  MAPKs 
were critical players in zinc-induced astroglia death. 
Addition  of  p38  MAPK  inhibitors,  SB202190  or 
SB203580,  in  culture  media  had  zinc-treated  astro-
glia  on  the  culture  plate  with  a  complete  attach-
ment.  Moreover,  zinc-treated  astroglia  appeared 
intact in the presence of SB203580 when examined 
by  a  phase-contrast  microscopy  (Fig.  2A∼D). 
However,  it  was  not  the  case.  The  zinc-challenged 
SB203580-cotreated  astroglia  cells  were  strongly 
stained by trypan-blue (Fig. 2E∼H), suggesting that 
they  were  not  alive.  Indeed,  LDH  assay  showed 
that  SB203580  and  SB202190  did  not  protect  from 
cell  death  of  zinc-treated  astroglia  (Fig.  2I).  Neither 
the JNK inhibitor, SP600125, nor the MEK inhibitor, 
PD98059,  produced  protective  effects  on  zinc- 
induced  cell  death  and  cell  morphology  disruption 
(Fig.  2I;  Table  1).
    The  treatment  of  primary  astroglia  with  Cd
2＋ ( 1 0
μM)  or  H2O2  (300μM)  also  activated  p38  MAPK 
and  caused  to  cell  death  (data  not  shown).  How-
ever, SB203580 did not prevent both morphological p 3 8  M A P K  a n d  C a
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Table  2.  Effects  of  the  p38  MAPK  inhibitor,  SB203580,  on 
morphological  disruption  and  cell  death  of  zinc-treated  C6 
glioma  and  NIH3T3  cells
Cell  types 
Zinc 
concentration 
Death 
protection 
Morphology 
protection 
Primary  astroglia  35μM  No  Yes 
C6  glioma  35μM  No  No 
NIH3T3  20μM  No  No 
Assays  were performed  24 hrs  after  Zn
2＋  treatment.  SB203580 
was  applied  to  cultures  1  h  before  Zn
2＋  treatment.  *SB203580 
concentration  was  20μM.
Table  3.  Effects  of  the  p38  MAPK  inhibitor,  SB203580,  on 
morphological  disruption  and  cell  death  of  H2O2-  or  cadmium- 
treated  primary  astroglia  culture
Stimuli  Concentration 
Death 
protection 
Morphology 
protection 
ZnSO4   3 5 μM  No  Yes 
H2O2 3 0 0 μM  No  Yes 
Cadmium    10μM  No  No 
Assays  were performed  24 hrs  after  Zn
2＋  treatment.  SB203580 
was  applied  to  cultures  1  h  before  Zn
2＋  treatment.  *SB203580 
concentration  was  20μM
Table  1.  Effects  of  various  cellular  factor  inhibitors  on  mor-
phological  disruption  and  cell  death  of  zinc-treated  astroglia
Inhibitors  Concentration 
Effects
Death 
protection
Morphology 
protection
Potein  kinase  inhibitors 
    PD98059    10∼20μM  No  No 
    SP600125    1∼20μM  No  No 
    SB203580    1∼20μM  No  Yes 
    SB202190  0.1∼20μM  No  Yes 
  G F X     1∼3μM  No  No 
  H 8 9     1μM  No  No 
  K N 6 2     1μM  No  No 
Phosphatase  inhibitors 
  O K A     1μM  No  No 
Antioxidants 
  N S 3 9 8     30∼100μM  No  No 
  D P I     1∼10μM  No  No 
    Allopurinol    1∼5  mM  No  No 
  P B N   2 0 0 ∼500μM  No  No 
    NAME    1∼5  mM  No  No 
    PDTC    25∼100μM  No  No 
    NDGA    10∼100μM  No  Yes 
Caspase  inhibitor 
  Z V A D     10∼30μM  No  No 
PARP  inhibitor 
    Benzimide    1∼5  mM  No  No 
Ca
2+  regulator 
    A23187  0.1∼1μM  No  Yes 
Assays  were  performed  24  h  after  Zn
2＋ ( 3 5 μM)-treatment. 
Inhibitors were applied to cultures 1 h prior to the start of Zn
2＋ 
treatment
disruption  and  cell  death  induced  by  Cd
2＋ o r  H 2O2 
(Table  2).  In  addition,  SB203580  did  not  suppress 
morphological disruption and cell death of zinc (100
μM)-treated C6 glioma cells and of zinc (100μM)- 
treated  NIH3T3  fibroblasts  (Table  3).  These  results 
raise  the  possibility  that  SB203580-dependent  mor-
phological  protection  is  a  process  that  is  a  distinct 
property  of  zinc-treated  primary  astroglia.
Supplement  of  intracellular  Ca
2＋  helped  the 
maintenance of cell morphology of zinc-insult-
ed  astroglia
    We searched for other cellular signaling pathways 
that produce morphological disruption of zinc-treated 
astroglia.  Inhibitors  of  ROS  generating  enzymes, 
namely  the  COX-2  inhibitor  NS398  (30μM),  the 
NADPH  oxidase  inhibitor  DPI  (1μM),  the  xanthine 
oxidase  inhibitor  allopurinol  (5μM  ),  and  the  NOS 
inhibitor  N-nitro-l-arginine  methyl  ester  (L-NAME)  (1 
mM),  and  the  free  radical  trapping  agent  phenyl- 
alpha-tert-butyl  nitrone  (PBN)  (200μM )  d i d  n o t  
affect  zinc-induced  morphological  changes.  In  addi-
tion, the caspase inhibitor zVAD (10μM), the PARP 
inhibitor  benzamide  (1  mM),  the  protein  phospha-
tase 2A inhibitor okadaic acid (OKA; 1μM), the NF-
κB inhibitor pyrrolidine dithiocarbamate (PDTC; 100
μM), protein kinase-A inhibitor H89 (1μM), the Ca
2＋- 
calmodulin-dependent  protein  kinase  (CAMK)  inhi-
bitor KN62 (1μM), and the protein kinase C (PKC) 
inhibitor  GF109203X  (GFX;  1μM)  were  also  in-
effective  (Table  1).
    Next,  we  examined  whether  cell  morphology  of 
zinc-treated  astroglia  can  be  regulated  by  Ca
2＋. 
Co-treatment  of  astroglia  with  A23187  (0.1μM),  a 
Ca
2＋  ionophore,  for  24  h  did  not  inhibit  zinc- 
induced  cell  death  (Fig.  3A),  but  did  suppress  cell 
morphology  disruption,  thus  leaving  zinc-treated 
cells  attached  on  the  culture  plate  (Fig.  3B∼E). 
Treatment  with  the  Ca
2＋  chelator,  BAPTA  (10μM) 
suppressed  cell  morphology  disruption  and  partially 
cell  death  of  zinc-insulted  astroglia  (Fig.  3F∼L). 
Together,  these  results  suggest  that  Ca
2＋ i s  i m -
portant  for  the  maintenance  of  cell  morphology  of 50 Joo-Young  Im,  et  al.
Fig.  3. T h e  C a
2+  ionophore,  A23187,  suppressed 
cell  morphology  disruption  of  zinc-treated 
astroglia.  (A)  LDH  assay  showing  cell  death 
levels  of  astroglia  treated  with  A23187  (0.1μ
M),  zinc  (35μM),  zinc  (35μM)＋A23187  (0.1
μM),  or  zinc  (35μM)＋SB203580  (20μM). 
LDH  assay  was  performed  after  24  h  of  drug 
treatment. (A) A23187; SB, SB203580. (B∼E) 
Trypan-blue  stained astroglia treated  with zinc 
(35μM),  zinc  (35μM)＋SB203580  (20μM), 
A23187  (0.1μM )  o r  z i n c  ( 3 5 μM)＋A23187. 
Photomicrographs  were  taken  after  24  h  of 
zinc  treatment  in  the  presence  of  SB203580 
or A23187. (F∼K) Trypan-blue stained astroglia 
with sham treatment (F, G), with zinc (H, I), or 
with  zinc  and  SB203580  (J,  K)  in  the  pre-
sence or absence of the Ca
2＋ chelator, BAPTA 
(10μM).  Photomicrographs  were  taken  24  h 
after treatment of zinc (35μM) and SB203580 
(20μM).  (L)  LDH  assay  showing  cell  death 
levels of astroglia treated with zinc (35μM) or 
zinc  (35μM)＋SB203580  (20μM)  in  the  pre-
sence  or  absence  of  BAPTA  (10μM).  LDH 
assay  was  performed  after  24  h  of  drug 
treatment.  Scale  bar  represents  100μm.  SB, 
SB203580. The data are presented as means 
±S.E.M.  (n=6∼12).  **Denotes  difference  at  p
＜0.05.
zinc-insulted  astroglia.
Zinc  influx  disrupted  actin  filament  organiza-
tion  in  astroglia,  which  was  reversed  by  p38 
inhibitors  or  A23187
    Because  cell  morphology  of  zinc-treated  astoglia 
was  retained  in  the  presence  of  SB203580  or 
A23187,  we  extended  our  efforts  to  visualize  the 
actin  organization  in  zinc-treated  astoglia.  Zinc- 
treated  astoglia  were  stained  with  TRITC-conjugat-
ed  phalloidin  which  labels  actin  fibers.  Microscopic 
examination  revealed  that  actin  fibers  in  untreated 
normal  astroglia  were  distributed  throughout  the 
cytoplasm,  along  with  a  mildly  preferential  localiza-
tion at the plasma membrane. After 9∼10 h of zinc 
treatment,  actin  filament  distribution  in  the  cyto-
plasm  was  disorganized  by  leaving  numerous 
patched  clumps  within  cells.  However,  in  the 
presence  of  SB203580,  zinc-induced  actin  filament 
disruption  disappeared,  and  instead  preferential 
distribution  of  actin  filament  at  the  cell  periphery 
was  strongly  reinforced,  giving  rise  to  a  distinct 
actin filament-ring along the plasma membrane (Fig. 
4A∼C).
    Because the Ca
2＋ ionophore, A23187, also main-
tained  cell  morphology  of  zinc-insulted  astroglia 
(Fig.  3B),  we  examined  whether  A23187  stabilized 
actin  filament  organization.  Phalloidin-staining  of 
zinc-treated  astroglia  showed  that  A23187  (0.1μM) 
protected  actin  filament  disruption  of  zinc-treated 
astroglia  so  that  the  resulting  actin  filament  dis-
tribution  was  indistinguishable  from  that  displayed 
by  untreated  astroglia.  A23187  did  not  produce 
actin-ring  formation  along  the  plasma  membrane 
(Fig.  4).
    Next,  we  tested  whether  Ca
2＋-mediated  process 
acts  over  the  p38  MAPK  pathway  in  zinc-insulted 
astroglia.  Western  blot  data  showed  that  A23187 
did  not  suppress  p38  MAPK  activation  in  zinc- 
treated astroglia (Fig. 5). These results suggest that 
Ca
2＋-mediated  process  is  not  in  the  up-stream  of 
p38  MAPK-mediated  process.
DISCUSSION
    The  present  study  demonstrates  that  the  Ca
2＋ 
ionophore  A23187  and  the  p38  MAPK  inhibitors 
(SB203580  and  SB202190)  suppressed  rapid  cell 
morphology  disruption  that  distinctly  occurs  in 
zinc-treated  astroglia.  These  results  suggest  that p 3 8  M A P K  a n d  C a
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Fig.  4.  SB203580  and  A23187  suppressed 
actin-filament disruption in zinc-treated astroglia. 
(A∼E) Photomicrographs showing actin-filament 
distributions  in  zinc-treated  astroglia  stained 
with TRITC-labeled phalloidin. Sham control (A) 
and  astroglia  treated  with  Zn  (35μM)  alone 
(B),  Zn  (35μM)＋SB203580  (20μM)  (C), 
A23187  (0.1μM)  alone  (D),  or  zinc  (35μM)＋
A23187  (0.1μM) (E). Actin-filament disruptions 
were  visualized  after  10  h  of  zinc  treatment. 
Scale  bar  represents  100  μm.
Fig.  5.  A23187  did  not  suppress  p38  MAPK  activation  in  zinc- 
treated  astroglia.  Western  blots  showing  p38  MAPK  activation 
levels  in  zinc-treated  astroglia.  Western  blot  analysis  was  per-
formed after 3 h of treatment with zinc (40μM) alone or zinc (40
μM)＋A23187  (A:  0.1μM).
Ca
2＋  signaling  and/or  the  p38  MAPK  pathway  are 
mechanism(s)  that  regulate  actin  filament  dynamics 
in  zinc-treated  astroglia.  A23187  produced  a  com-
pletely  protection  of  cell  morphology  and  actin-fila-
ment  stabilization  in  zinc-treated  astroglia,  whereas 
SB203580 produced similar stabilization effects with 
leaving  abnormally  intensified  actin  filament-ring 
formation along the cell membrane, suggesting that 
in  zinc-insulted  astroglia,  zinc  influx-induced  distur-
bance  of  cell  morphology  might  be  diverse.
    The  present  study  demonstrates  that  supplement 
of  Ca
2＋  into  zinc-treated  astroglia  using  the  Ca
2＋ 
ionophore,  A23187,  protected  cell  morphology  dis-
ruption  of  zinc-treated  astroglia.  Therefore,  we 
speculate that zinc influx disrupts Ca
2＋ homeostasis 
or  Ca
2＋  availability  in  zinc-treated  astroglia,  which 
in  turns  affects  actin  filament  destabilization,  result-
ing  in rapid  loss of  the  morphological  integrity. Dis-
ruption  of  Ca
2＋  availability  or  substitution  of  Ca
2＋ 
by  Zn
2＋  might  affect  the  function  of  Ca
2＋-depen-
dent  proteases  or  Ca
2＋  regulating  factors  such  as 
calreticulin  and  calbibdin.  For  examples,  calpains 
are  Ca
2＋-dependent  proteases  that  cleave  actin- 
binding  proteins  (Harris  and  Morrow,  1990;  Carrag-
her and Frame, 2002). Calreticulin potentially has a 
role  in  cell  adhesion  and  maintenance  of  intra-
cellular  Ca
2＋  homeostasis  (Michalak  et  al.,  1998). 
Zinc  influx  induces  functional  disruption  of  thiol- 
containing cellular factors (Frederickson et al., 1988; 
Kim et  al., 2003) and  increase of  ROS  stress  (Kim 
et al., 1999a; 1999b; Suh et al., 2000). Our results 
add the evidence that zinc influx in astroglia causes 
a  disturbance  of  Ca
2＋  homeostasis.
Concerning  the  effects  of  SB203580  on  cell 
morphology  and  actin  filament  dynamics,  it  may  be 
possible that the p38 MAPK pathway normally plays 
an  inhibitory  role  in  actin  filament  stabilization  in 
zinc-treated  astroglia.  The  notion  that  inhibition  of 
p38  MAPK  pathway  by  SB203580  enhances  actin 
filament  stabilization  is  consistent  with  the  previous 
report  that  inhibition  of  the  p38  MAPK  pathway  by 
SB202190  facilitated  stellate  process  growth  and 
extension of FGF2-treated primary astroglia (Heffron 
and  Mandell,  2005).  Stellate  process  extension  of 
astroglia  is  an  important  aspect  of  reactive  astro-
gliosis that occurs in a variety of pathological stimuli 
including  trauma,  ischemia,  and  neurodegenerative 
diseases  (Chen  and  Swanson,  2003;  Pekny  and 
Nilsson,  2005).  During  the  changes  of  stellate 
process extension of astroglia, actin filament break-
down,  reassembly  and  stabilization  should  take 
place  rapidly.  Consistent  with  this  view,  reactive 
astrogliosis  express  high  levels  of  p38  MAPK  (Che 
et  al.,  2001;  Piao  et  al.,  2003).  Many  brain  tumors 
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may  undergo  a  phase  in  which  cell  adhesion  and 
cell  morphology  changes  are  critical  steps.  The 
results of the present study may raise the possibility 
that the p38 MAPK pathway is an important regula-
tor of morphological behaviors of brain cells with an 
astroglia-origin.
    A23187 did not suppress p38 MAPK activation in 
zinc-treated  astroglia  and  both  factors  distinctly 
regulate  actin-filament  organization.  Therefore,  we 
speculate  that  SB203580/SB202190  target(s)  and 
Ca
2＋  signaling  players  independently  work  to 
stabilize  cell  morphology.  Cell  morphology  preser-
vation  of  zinc-treated  astroglia  by  SB203580  and 
SB202190  is  likely  produced  by  stabilization  of 
actin-filament  organization  by  inhibiting  p38  MAPK. 
However,  we  do  not  rule  out  the  possibility  that 
SB203580/SB202190  targets  unidentified  cellular 
factors  regulating  actin-filament  organization.  Our 
preliminary  data  showed  that  cell  morphology  sta-
bilization,  but  no  cell  death  protection,  of  zinc- 
treated  astroglia  can  be  also  achieved  by  NDGA 
(nordihydroguaiaretic  acid),  which  possess  a  lipoxy-
genase  (LOX)  inhibition  activity  and  an  anti-oxidant 
property (Konno et al., 1990; Arteaga et al., 2005), 
and  causes  GSH  depletion  (Im  and  Han,  2007). 
Regarding  that  A23187,  SB202190  and  NDGA 
might  distinctly work  within cells,  the possibility  that 
they may act on a common pathway still remains to 
be  explored  further  in  the  future.
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